# NF-1, Nutraceutical Intervention

> **NCT05363267** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 23 (actual)

## Conditions studied

- Neurofibromatosis 1

## Interventions

- **DIETARY_SUPPLEMENT:** curcumin, high phenolic extra virgin olive oil (HP-EVOO)

## Key facts

- **NCT ID:** NCT05363267
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-06
- **Primary completion:** 2025-09-02
- **Final completion:** 2026-08
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05363267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05363267, "NF-1, Nutraceutical Intervention". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05363267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*